Lennox-Gastaut syndrome: genes and variants
Explore variant evidence for Lennox-Gastaut syndrome across 13 analyzed proteins (CCND2, DNM1, CA2, GABRA1, GABRB3 and 8 more). Linked ClinVar records include 1 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Lennox-Gastaut syndrome
CCND2: G1/S-specific cyclin-D2
It promotes G1-to-S cell-cycle progression through activation of CDK4 and CDK6 and is important in proliferating neural and endocrine tissues. Activating germline variants can cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, while overexpression occurs in several cancers.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CCND2 have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
DNM1: Dynamin-1
It drives membrane fission during synaptic-vesicle endocytosis, allowing rapid recycling of vesicles after neurotransmitter release. De novo pathogenic variants can cause severe developmental and epileptic encephalopathy with profound developmental impairment.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DNM1 have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
CA2: Carbonic anhydrase 2
It rapidly interconverts carbon dioxide and bicarbonate, supporting acid-base balance, renal acidification, respiration, bone remodeling, and fluid secretion. Biallelic loss-of-function variants cause carbonic anhydrase II deficiency, with osteopetrosis, renal tubular acidosis, and cerebral calcification.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CA2 have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
GABRA1: Gamma-aminobutyric acid receptor subunit alpha-1
The gene product supplies the alpha-1 subunit of a pentameric GABA-A receptor, a ligand-gated chloride channel in the brain. GABA binding allows chloride influx that dampens neuronal activity, making this receptor important for inhibition and seizure biology.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GABRA1 have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
GABRB3: Gamma-aminobutyric acid receptor subunit beta-3
It contributes to inhibitory GABA-A receptor currents in the brain and is particularly important during neurodevelopment. Pathogenic variants can cause developmental and epileptic encephalopathy, while altered dosage within chromosome 15q11-q13 contributes to neurodevelopmental disorders.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GABRB3 have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
GABRG2: Gamma-aminobutyric acid receptor subunit gamma-2
The gene product supplies the gamma-2 subunit of synaptic GABA-A receptors, which are pentameric chloride channels activated by the inhibitory neurotransmitter GABA. The subunit helps receptor assembly and localization at neuronal membranes, and GABRG2 variants are associated with several epilepsy syndromes.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GABRG2 have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
GRIA1: Glutamate receptor 1
An AMPA-type glutamate receptor subunit that forms a ligand-gated cation channel at excitatory synapses. Glutamate opens the receptor to convert a chemical signal into an electrical response, supporting fast transmission and activity-dependent plasticity in the brain.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GRIA1 have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
GRIA2: Glutamate receptor 2
An AMPA-type glutamate receptor subunit that contributes to fast excitatory signaling in the nervous system. Together with other subunits it forms a glutamate-gated cation channel, and its presence helps shape the channel's ion permeability and synaptic behavior.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GRIA2 have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
SCN10A: Sodium channel protein type 10 subunit alpha
The protein forms Nav1.8, a tetrodotoxin-resistant voltage-gated sodium channel found in excitable membranes. It helps generate sensory-neuron electrical signals and is especially important in mechanisms of neuropathic pain and inherited episodic pain.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN10A have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
SCN1A: Sodium channel protein type 1 subunit alpha
Its sodium current is especially important for reliable firing of inhibitory interneurons and therefore for balancing excitation across neural networks. Loss-of-function variants are the major cause of Dravet syndrome, while other variants cause GEFS+ or familial hemiplegic migraine.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN1A have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
SCN2A: Sodium channel protein type 2 subunit alpha
The protein forms Nav1.2, a voltage-gated sodium channel that carries sodium current during neuronal action potentials. By shaping neuronal excitability and signal propagation, it supports brain circuits involved in development, learning, and seizure susceptibility.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN2A have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
SCN8A: Sodium channel protein type 8 subunit alpha
The protein forms Nav1.6, a voltage-gated sodium channel that sets the threshold and propagation of neuronal action potentials. It is widely important for neuronal excitability, and SCN8A variants are associated with developmental and epileptic encephalopathies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN8A have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
SCN9A: Sodium channel protein type 9 subunit alpha
The protein forms Nav1.7, a voltage-gated sodium channel that amplifies electrical signals in peripheral sensory neurons. Changes in Nav1.7 activity can produce either excessive pain or congenital insensitivity to pain, making SCN9A central to pain biology.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN9A have source records linked to Lennox-Gastaut syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): GRIN2B.
ClinVar pathogenic and likely pathogenic variants linked to Lennox-Gastaut syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CCND2 T280N | 280 | Pathogenic / likely pathogenic (★★) |
Same protein, different disease
- Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome also has ClinVar records linked to CCND2 variants; they fall partly in the same places as the Lennox-Gastaut syndrome variants (7 pathogenic / likely pathogenic).
Diseases related to Lennox-Gastaut syndrome
- Epilepsy, also linked to CA2, GABRA1, GABRB3, GABRG2 and 7 more
- Migraine, also linked to CA2, GABRA1, GABRB3, GABRG2 and 7 more
- Developmental and epileptic encephalopathy, also linked to DNM1, GABRA1, GABRB3, GABRG2 and 3 more
- Amyotrophic lateral sclerosis, also linked to SCN10A, SCN1A, SCN2A, SCN8A and 1 more
- Cardiac arrhythmia, also linked to SCN10A, SCN1A, SCN2A, SCN8A and 1 more
- Focal epilepsy, also linked to SCN10A, SCN1A, SCN2A, SCN8A and 1 more
- Genetic developmental and epileptic encephalopathy, also linked to GABRG2, SCN1A, SCN2A and SCN8A
- Generalized epilepsy with febrile seizures plus, also linked to GABRG2, SCN1A and SCN9A
- EPILEPSY, CHILDHOOD ABSENCE, also linked to GABRA1, GABRB3 and GABRG2
- Early-infantile DEE, also linked to SCN1A and SCN8A
- Seizures, benign familial, also linked to SCN2A and SCN8A
- Complex neurodevelopmental disorder, also linked to SCN2A and SCN8A
Frequently asked questions
Which genes have records linked to Lennox-Gastaut syndrome?
This view contains 13 analyzed proteins: CCND2, DNM1, CA2, GABRA1, GABRB3 and 8 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 1 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 101 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center